| Parameters | Relapsed | Total | p | |
| Associated malformations | Yes | No |
|
|
| Yes | 4 (3.12) | 1 (0.8) | 5 (3.9) | 0.0002 |
| No | 8 (6.25) | 115 (89.8) | 123 (96.1) |
|
| Patients’surgical stories |
|
|
|
|
| Operated directly | 3 (2.34) | 0 | 3 (2.34) | 0.0006 |
| Operated after chemotherapy | 9 (7.03) | 116 (90.63) | 125 (97.66) |
|
| Neoadjuvant chimiotherapy |
|
|
|
|
| Yes | 9 (7.07) | 116 (90.63) | 125 (97.66) | 0.0006 |
| No | 3 (2.34) | 0 | 3 (2.34) |
|
| Number of chemotherapy sessions |
|
|
|
|
| <4 | 7 (5.5) | 5 (3.9) | 12 (9.4) | 0.0000 |
| ≥4 | 5 (3.9) | 111 (86.7) | 116 (90.6) |
|
| Tumor resection |
|
|
|
|
| Completed | 7 (5.5) | 116 (90.63) | 123 (96.1) | 0.0000 |
| Non completed | 5 (3.9) | 0 | 5 (3.9) |
|
| Preoperative tumor rupture |
|
|
|
|
| Yes | 3 (2.34) | 1 (0.8) | 4 (3.12) | 0.0024 |
| No | 9 (7.03) | 115 (89.8) | 124 (96.88) |
|
| Capsular Damage |
|
|
|
|
| Yes | 3 (2.34) | 6 (4.7) | 9 (7.03) | 0.0387 |
| No | 9 (7.03) | 110 (85.9) | 119 (92.97) |
|
| Surgical Stage |
|
|
|
|
| I | 0 | 42 (32.81) | 42 (32.81) |
|
| II | 3 (2.34) | 52 (40.7) | 55 (42.97) |
|
| III | 6 (4.7) | 12 (9.4) | 18 (14.1) | 0.0003 |
| IV | 3 (2.34) | 9 (7.03) | 12 (9.4) |
|
| V | 0 | 1 (0.8) | 1 (0.8) |
|